Glaukos Corp
(FRA:6GJ)
€
119
0 (0%)
Market Cap: 6.63 Bil
Enterprise Value: 6.53 Bil
PE Ratio: 0
PB Ratio: 10.75
GF Score: 61/100 
Glaukos Corp at Bank of America Merrill Lynch Health Care Conference Transcript
May 14, 2019 / 10:40PM GMT
Release Date Price:
€58.71
(-1.21%)
Robert Adam Hopkins
BofA Merrill Lynch, Research Division - MD of Equity Research
We have Glaukos. Very happy to have you guys here this year. Thanks very much for coming.
Joseph E. Gilliam
Glaukos Corporation - CFO & Senior VP of Corporate Development
Thanks for having us.
Robert Adam Hopkins
BofA Merrill Lynch, Research Division - MD of Equity Research
Appreciate it. Good trip from California.
I think everybody knows the folks on the podium. We have Joe, the company's CFO; Chris, who's the Chief Commercial Officer. I don't know if you guys have anything, any kind of messaging you want to deliver, or we'll get right into Q&A. It's totally up to you guys.
Joseph E. Gilliam
Glaukos Corporation - CFO & Senior VP of Corporate Development
I think coming off an earnings call, we've probably said about everything we need to say. So we can jump right in.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers